Transcutaneous Auricular Neurostimulation (tAN®) Clinical Trial Results

FDA-Cleared, Clinically Proven Results

Sparrow Ascent is the first and only FDA-cleared device for opioid withdrawal supported by evidence from a Level 1, double-blinded, randomized controlled clinical trial targeting patients with opioid use disorder.

Complete the form to get your copy of the white paper containing more detailed research results from the Sparrow Therapy System clinical trial.

Download the Updated Clinical Trial Whitepaper
Download Today